Balasubramanian Dorairajan
Director/Board Member at Bharat Biotech International Ltd.
Profile
Balasubramanian Dorairajan is currently a Director at Bharat Biotech International Ltd.
He was previously an Independent Non-Executive Director at Vimta Labs Ltd.
from 2004 to 2019.
He also held a Director position at the Center for Cellular & Molecular Biology.
Dorairajan earned a doctorate degree from The Trustees of Columbia University in The City of New York.
Balasubramanian Dorairajan active positions
| Companies | Position | Start |
|---|---|---|
Bharat Biotech International Ltd.
 Bharat Biotech International Ltd. BiotechnologyHealth Technology Bharat Biotech International Ltd. engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics. It focuses on the development of novel health care solutions for region-specific neglected diseases. The firm offers Revac-B+, REGEN-D, HNVAC, COMVAC5, BIOPOLIO, INDIRAB, Typbar TCV, BIOHIB, JENVAC, ROTAVAC and vaccine candidates against chikungunya, chandipura, HPV and Ebola. The company was founded by Krishna Murthy Ella and Suchitra K. Ella in 1996 and is headquartered in Hyderabad, India.. | Director/Board Member | 31/03/2015 |
Former positions of Balasubramanian Dorairajan
| Companies | Position | End |
|---|---|---|
| VIMTA LABS LIMITED | Director/Board Member | 31/03/2019 |
| Center for Cellular & Molecular Biology | Director/Board Member | - |
Training of Balasubramanian Dorairajan
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VIMTA LABS LIMITED | Commercial Services |
| Private companies | 1 |
|---|---|
Bharat Biotech International Ltd.
Bharat Biotech International Ltd. BiotechnologyHealth Technology Bharat Biotech International Ltd. engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics. It focuses on the development of novel health care solutions for region-specific neglected diseases. The firm offers Revac-B+, REGEN-D, HNVAC, COMVAC5, BIOPOLIO, INDIRAB, Typbar TCV, BIOHIB, JENVAC, ROTAVAC and vaccine candidates against chikungunya, chandipura, HPV and Ebola. The company was founded by Krishna Murthy Ella and Suchitra K. Ella in 1996 and is headquartered in Hyderabad, India.. | Health Technology |
- Stock Market
- Insiders
- Balasubramanian Dorairajan
